| Market Cap | 8.74K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -5.74M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -98.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -100.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -100.00% |
| Recommedations | - | Quick Ratio | 0.06 | Shares Outstanding | 87.35M | 52W Low Chg | - |
| Insider Own | - | ROA | -103.99% | Shares Float | 22.46M | Beta | 24.12 |
| Inst Own | - | ROE | -568.90% | Shares Shorted/Prior | -/- | Price | 0.00010 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 242 | Target Price | - |
| Oper. Margin | - | Earnings Date | - | Volume | 1,000 | Change | 0.00% |
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona.